全文获取类型
收费全文 | 2280篇 |
免费 | 122篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 159篇 |
妇产科学 | 61篇 |
基础医学 | 402篇 |
口腔科学 | 36篇 |
临床医学 | 144篇 |
内科学 | 385篇 |
皮肤病学 | 68篇 |
神经病学 | 220篇 |
特种医学 | 26篇 |
外科学 | 177篇 |
综合类 | 31篇 |
一般理论 | 1篇 |
预防医学 | 92篇 |
眼科学 | 80篇 |
药学 | 267篇 |
中国医学 | 18篇 |
肿瘤学 | 232篇 |
出版年
2024年 | 3篇 |
2023年 | 14篇 |
2022年 | 34篇 |
2021年 | 69篇 |
2020年 | 44篇 |
2019年 | 45篇 |
2018年 | 60篇 |
2017年 | 46篇 |
2016年 | 57篇 |
2015年 | 84篇 |
2014年 | 85篇 |
2013年 | 125篇 |
2012年 | 194篇 |
2011年 | 192篇 |
2010年 | 93篇 |
2009年 | 82篇 |
2008年 | 181篇 |
2007年 | 162篇 |
2006年 | 145篇 |
2005年 | 133篇 |
2004年 | 117篇 |
2003年 | 106篇 |
2002年 | 92篇 |
2001年 | 26篇 |
2000年 | 22篇 |
1999年 | 25篇 |
1998年 | 20篇 |
1997年 | 14篇 |
1996年 | 7篇 |
1995年 | 15篇 |
1994年 | 7篇 |
1993年 | 11篇 |
1992年 | 13篇 |
1991年 | 10篇 |
1990年 | 13篇 |
1989年 | 8篇 |
1988年 | 7篇 |
1987年 | 8篇 |
1986年 | 7篇 |
1985年 | 5篇 |
1984年 | 3篇 |
1983年 | 3篇 |
1980年 | 3篇 |
1978年 | 4篇 |
1977年 | 3篇 |
1975年 | 2篇 |
1974年 | 3篇 |
1972年 | 2篇 |
1971年 | 2篇 |
1970年 | 2篇 |
排序方式: 共有2415条查询结果,搜索用时 31 毫秒
1.
2.
3.
M Vijaya Lakshmi MRCP G V Sridharan MRCP D Butterworth MRCP 《International journal of clinical practice》1993,47(3):164-165
Gallstones are common and their incidence increases with age.1 Fifty per cent of these stones are in the common bile duct (CBD) in the elderly.2 Most of them are silent but with time there is an increasing chance of developing symptoms which are more likely to be serious in the elderly.3 Failure to relieve mechanical obstruction of bile flow may lead to secondary biliary cirrhosis.4 It has been estimated that on average secondary biliary cirrhosis develops some seven years after the onset of obstruction from a stricture, four and half years after gallstone obstruction and 10 months after the onset of malignant stricture.5 The characteristic features are the pathological findings of portal-portal linkages, with a pattern of monolobular cirrhosis and the preservation of normal vascular relationships.6 Secondary biliary cirrhosis may lead to hepatic insufficiency and portal hypertension with the resultant complications, such as bleeding oesophageal varices, hypersplenism with pancytopenia, ascites and encephalopathy. We describe a patient in whom the diagnosis was not suspected until laparotomy and confirmed only at autopsy. 相似文献
4.
The expression of alpha melanocyte stimulating hormone (MSH) has been investigated in two variants of the B16 murine melanoma. The presence of MSH was demonstrated by immunohistochemical methods using anti-MSH antibodies. The low metastasis variant B16-F1, which grows as an encapsulated non-invasive tumour, showed no alpha-MSH immunoreactivity. In contrast, the high metastasis variant BL6 was found to be alpha-MSH positive and the immunoreactivity was found predominantly in the peripheral invading zones of the tumour. 相似文献
5.
6.
目的:应用酵母双杂交方法筛选BRCA2相互作用蛋白编码基因,验证其相互作用并研究其功能联系。方法:以BRCA2基因3′端片段构建酵母双杂交质粒,筛选正常人乳腺上皮细胞cDNA库,获得编码相互作用蛋白的基因,采用免疫共沉淀、哺乳细胞双杂交和荧光酶测定等方法进一步验证蛋白间相互作用和功能联系.结果:采用酵母双杂交系统筛选,获得了多个编码BRCA2相互作用蛋白的基因,其中包括已知的FHL2蛋白;免疫共沉淀和哺乳动物细胞双杂交试验显示BRCA2和FHL2在体内特异性结合,并证实FHL2在体内形成同源二聚体;转录活性分析发现BRCA2与FHL2有协同转录激活作用。结论:发现BRCA2与FHL2蛋白间相互作用和功能联系,为BRCA2功能研究提供了新的方向。 相似文献
7.
Uttam C. Garg Lakshmi Devi Herman Turndorf Lewis R. Goldfrank Mylarrao Bansinath 《Brain research》1992,592(1-2):208-212
In the brain, nitric oxide (NO) has been identified as a messenger molecule and a mediator of excitatory amino acid-induced neurotoxicity. In this study, the effects of NO on serum-induced mitogenesis and cell proliferation of the cerebellar glial cells were assessed. NO-generating agent, S-nitroso-N-acetylpenicillamine (SNAP) increased intracellular cyclic guanosine monophosphate (cGMP) levels. Furthermore, 2 chemically dissimilar NO-generating agents, SNAP and sodium nitroprusside (SNP) inhibited serum-induced thymidine incorporation and cell proliferation. The antimitogenic effect of NO was mimicked by 8-bromo-cGMP and blocked by hemoglobin, a known inhibitor of NO. The effect of NO was not cytotoxic, since the cells were not stained with Trypan blue and did not show increased release of lactate dehydrogenase in the culture supernatants. However, NO-treated cells showed decreased conversion of tetrazolium to blue formazan suggesting that NO inhibited mitochondrial activity in the glial cells. These results demonstrate that NO inhibits serum-induced mitogenesis and cell proliferation of cultured rat cerebellar glial cells. 相似文献
8.
Lakshmi Pendyala Patrick J. Creaven Robert Huben Dominique Tremblay Christine Bertagna 《Cancer chemotherapy and pharmacology》1988,22(1):69-76
Summary The pharmacokinetics of total radioactivity and unchanged drug were studied in patients receiving Anandron (Nilutamide, RU 23908) after a single dose of [14C] Anandron and after q12 h dosings of unlabelled drug for 2–7 weeks. The results indicate that the radioactivity in plasma consists of unchanged drug and metabolites. The plasma decay of Anandron after the absorption phase was biexponential in all patients, with the terminal phase half-life ranging from 23.3–87.2 h. The plasma decay of total radioactivity after the absorption phase was biexponential in 3/12 and monoexponential in 9/12 patients. The calculated terminal phase half-lives for total radioactivity after [14C] Anandron were 34.5–137.3 h. The AUC0– of the unchanged drug in plasma represented 23%–38% of the AUC0– of total radioactivity. Urinary radioactivity consisted primarily of metabolites, the majority of which were chloroform-nonextractable. Urinary excretion of radioactivity at 120 h ranged from 49%–78% of the administered dose; the unchanged Anandron (at 72 h) was 0.6%–1.3% of the dose. In three patients studied, the fecal excretion of Anandron was 1.4%–7.0%. Steady-state plasma levels (4.4–8.5 g/ml) were attained within approximately 2 weeks from the initiation of twice daily dosing of Anandron. When the plasma pharmacokinetics of radioactivity and unchanged drug after the first single dose were compared with that during steady state, AUC0–12 h of unchanged Anandron during steady state was significantly higher than the AUC0– after the first single dose, suggesting that the plasma clearance of Anandron is lowered upon chronic administration of the drug, assuming that the bioavailability is constant. 相似文献
9.